Dimerix Limited Banner Image

Dimerix Limited

  • Ticker DXB
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Dimerix Limited Logo Image
  • 1-10 Employees
  • Based in Fitzroy, Australia
Dimerix Limited, a clinical-stage biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs. The company develops DMX-200 that is in two Phase 3 clinical trials for COVID respiratory complications; DMX-200, a Phase 3 clinical trial for focal segmental glomerulosclerosis disease; and DMX-700 that is in pre-clinical development for chronic obstructiveMore pulmonary disease. The company was founded in 2004 and is headquartered in Fitzroy, Australia.
Dimerix Limited

Most Recent Annual Report

Dimerix Limited
MOST RECENT 2020 Annual Report

Older/Archived Annual Reports